Soft tissue neoplasms: a clinicopathological study
DOI:
https://doi.org/10.18203/2320-6012.ijrms20204234Keywords:
Soft tissue, Neoplasm, Sarcoma, MalignantAbstract
Background: The current WHO classification has categorized soft tissue tumours into benign, malignant and so-called intermediate neoplasms. Soft tissue sarcoma comprises <1% of adult cancers. The aim of the study was to clinically correlate soft tissue neoplasms and study the histomorphological features of various malignant soft tissue tumors.
Methods: This was a retrospective study conducted in a tertiary care hospital in Mangalore, India from January 2019 to June 2020. Clinical details of all cases of soft tissue neoplasms retrieved from the medical records of our institution. Data collected included age, gender, presenting symptoms, site and size of soft tissue neoplasms and clinical diagnosis. Pathological diagnosis of these tumours was made and details recorded.
Results: A total of 113 cases of soft tissue neoplasms were collected. 94.4% benign and 18.6 %. malignant tumours were present. 77% cases presented with swelling whereas 23% presented with pain. Majority of benign soft tissue tumours were located in the trunk (36.9%) and the most common type was lipomas (66.38%). Malignant soft tissue tumours showed male to female ratio of 1.33:1. Most predilection was noted for the extremities (42.8%) and leiomyosarcomas were the most common type (38%).
Conclusions: The incidence of malignant soft tissue tumours is rare. Majority of the cases were noted in the extremities. Leiomyosarcoma was the most common type, in our study. Lipomas were the most common benign soft tissue tumours, and majority of the benign tumours were located in the trunk.
References
Enzinger FM, Weiss SW. Soft tissue tumors. 4th edn. Missouri: Mosby Company. 2001:1-5.
Bhosle RV, Sreenivasa P. A hospital-based clinic-pathological study of soft tissue tumours. Surgical Update: Int J surg Orthope. 2018;4(1):24-8.
Venkatraman J, Rathna S, Kotasthane DS, Govindaraj T. Clinicopathological Study of Malignant Soft Tissue Tumors. J of Evolution of Med Dent Sci. 2014;3(71):15083-9.
Renne SL. Who, how and what of pathology of soft tissue sarcoma. Chin Clin Oncol. 2018:1-11.
Fletcher CDM. Diagnostic Histopathology of Tumours. 4th edn, vol 2, Churchill Livingstone. Elsevier Saunders, Philadelphia. 2013:1796-1800.
Bajpai J, Khanna N, Vora T, Gulia A, Laskar S, Puri A et al. Analysis of bone and soft tissue sarcomas registered during the year 2012 at Tata Memorial Hospital, Mumbai, with clinical out-comes. Indian J Cancer. 2018;55:37-44.
Ramaswamy A, Rekhi B, Agarwal M. Indian data on bone and soft tissue sarcomas: A summary of published study results. South Asian J Cancer. 2016;5(3):138-45.
Dreinhofer KE, Baldetorp B, Akerman M, Ferno M, Rydholm A, Gustafson P. DNA ploidy in soft tissue sarcoma: comparison of flow and image cytometry with clinical follow up in 93 patients. Cytometry. 2002;50:19-24.
Baste BD, Swami SY, Narhire VV, Dhamecha MP, D’Costa G. A clinicopathological study of soft tissue neoplasms: An experience from a rural tertiary care hospital. Ann Trop Med Pub Health. 2017:10:348-52.
Ramnani BG, Kumar A, Chandak S, Ranjan A, Patel MK. Clinicopathological Profile of Benign Soft tissue Tumours: A Study in a Tertiary Care Hosipital in Western India. J Clin Diag Res. 2014;8(10):FC01-4.
Jenna P, Sushma J, Kartheek BVS, Lakshmi AB, Chapara V. Study of soft tissue sarcomas over a period of 3 years. Int J Res Med Sci. 2017;5:2678-83.
Aliyu UM, Okuofo EC, Okwonna CO, Sahabi SM. Clinicopathological pattern of soft tissue sarcoma in a tertiary health institution in North Western Nigeria. Int J Res Med Sci. 2018;6:1632-8.
Gulia A, Puri A, Chorge S, Panda PK. Epidemiological data and case load spectrum of patients presenting to bone and soft tissue disease management group at a tertiary cancer center. Indian J Cancer. 2016;53:333-8.
Fang Z, Chen J, Teng S, Chen Y, Xue R. Analysis of soft tissue sarcomas in 1118 cases. Chin Med J. 20095;122(1):51-3.
